Anzeige
Mehr »
Login
Montag, 03.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Trumps Krypto-Reserve löst Markt-Explosion aus - Pioneer AI Foundry setzt auf Solana!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 07.02.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
07.02.Punktid Technologies: Delisting from the Stock Exchange33Punktid Technologies AS hereby announces that the stock exchange has initiated supervisory proceedings regarding Punktid Technologies AS, which may result in a sanction, including the potential termination...
► Artikel lesen
07.02.Pliant Therapeutics, Inc.: Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis412Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed SOUTH SAN FRANCISCO...
► Artikel lesen
07.02.Mexco Energy Corp.: Mexco Energy Corporation Reports Financial Results for Third Quarter108MIDLAND, TX, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) today reported net income of $1,077,370, or $0.51 per diluted share, for the nine months ending December...
► Artikel lesen
07.02.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)98SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
07.02.Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)87CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives...
► Artikel lesen
07.02.Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)154BRISBANE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics...
► Artikel lesen
07.02.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)100MALVERN, Pa., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
► Artikel lesen
07.02.Parks! America, Inc. Reports First Quarter Fiscal Year 2025 Financial Results100Management to host conference call on Monday, February 10, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCPink: PRKA), today announced its financial...
► Artikel lesen
07.02.Friedman Industries Inc.: Friedman Industries, Incorporated Announces Third Quarter Results115LONGVIEW, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Friedman Industries, Incorporated (NYSE American: FRD) announced today its results of operations for the third fiscal quarter ended December 31,...
► Artikel lesen
07.02.Beyond Oil Ltd.: Beyond Oil Expands into Sweden with 5-Year Distribution Agreement454VANCOUVER, BC and KIBBUTZ YIFAT, Israel, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9) ("Beyond Oil" or the "Company"), a food-tech innovation company...
► Artikel lesen
07.02.Brera Holdings PLC: Brera Holdings Announces Anticipated Receipt of Nasdaq Additional Deficiency Notice203Dublin, Ireland, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Brera Holdings PLC ("Brera Holdings" or "the Company") (Nasdaq: BREA), an Ireland-based, Nasdaq-listed, international holding company focused on...
► Artikel lesen
07.02.Callan JMB Inc.: Callan JMB Announces Partial Exercise of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering132SPRING BRANCH, Texas, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) ("Callan" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency...
► Artikel lesen
07.02.Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)179CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug...
► Artikel lesen
07.02.AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards139IRVINE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under...
► Artikel lesen
07.02.Retail Opportunity Investments Corp. Stockholders Approve Acquisition by Blackstone Real Estate1.219SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ: ROIC) ("ROIC" or the "Company") today announced that, at the concluded special meeting of stockholders held...
► Artikel lesen
07.02.Ottawa Bancorp, Inc. Announces Fourth Quarter and Fiscal 2024 Results and 2025 Annual Meeting Date117OTTAWA, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the "Company") (OTCQX: OTTW), the holding company for OSB Community Bank (the "Bank"), announced net income of $0.5 million, or...
► Artikel lesen
07.02.Replimune Group Inc: Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)129WOBURN, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced...
► Artikel lesen
07.02.NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)89NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company...
► Artikel lesen
07.02.Pharming Group N.V.: Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period132This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation...
► Artikel lesen
07.02.Track Group Reports 1st Quarter Fiscal 2025 Financial Results160NAPERVILLE, Ill., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal...
► Artikel lesen
Seite:  Weiter >>